These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Altered Expression Levels of MMP1, MMP9, MMP12, TIMP1, and IL-1β as a Risk Factor for the Elevated IOP and Optic Nerve Head Damage in the Primary Open-Angle Glaucoma Patients. Markiewicz L, Pytel D, Mucha B, Szymanek K, Szaflik J, Szaflik JP, Majsterek I. Biomed Res Int; 2015; 2015():812503. PubMed ID: 26120586 [Abstract] [Full Text] [Related]
4. Role of functional single nucleotide polymorphisms of MMP1, MMP2, and MMP9 in open angle glaucomas. Mossböck G, Weger M, Faschinger C, Zimmermann C, Schmut O, Renner W, El-Shabrawi Y. Mol Vis; 2010 Aug 28; 16():1764-70. PubMed ID: 20808730 [Abstract] [Full Text] [Related]
5. Polymorphisms in matrix metalloproteinases MMP1 and MMP9 are associated with primary open-angle and angle closure glaucoma in a Pakistani population. Micheal S, Yousaf S, Khan MI, Akhtar F, Islam F, Khan WA, den Hollander AI, Qamar R, Ahmed A. Mol Vis; 2013 Aug 28; 19():441-7. PubMed ID: 23441116 [Abstract] [Full Text] [Related]
13. Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Hu C, Wang J, Xu Y, Li X, Chen H, Bunjhoo H, Xiong W, Xu Y, Zhao J. Gene; 2013 Mar 15; 517(1):65-71. PubMed ID: 23313298 [Abstract] [Full Text] [Related]
14. The association of matrix metalloproteinases polymorphisms and interleukins in advanced age-related macular degeneration. Budiene B, Liutkeviciene R, Gustiene O, Ugenskiene R, Laukaitiene D, Savukaityte A, Vilkeviciute A, Steponaviciute R, Rocyte A, Zaliuniene D. Ophthalmic Genet; 2018 Aug 15; 39(4):463-472. PubMed ID: 29947568 [Abstract] [Full Text] [Related]